Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Oncology|July 24, 2025
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113Yuko Suzuki, Masafumi Ikeda, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|January 8, 2025
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113Koh Fukushi, Hiroshi Imaoka, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|March 7, 2025
Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113Mao Okada, Eiichiro Suzuki, Chigusa Morizane, et al.
Cancer Science|November 21, 2019
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapyMakoto Sugimori, Kazuya Sugimori, Hiromi Tsuchiya, et al.
International Journal of Clinical Oncology|October 23, 2024
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113Tatsuya Okuno, Chigusa Morizane, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|December 30, 2021
Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial chemotherapy (GASPACHO study): a multicenter retrospective studyNobuaki Azemoto, Makoto Ueno, Hiroaki Yanagimoto, et al.
Japanese Journal of Clinical Oncology|June 6, 2024
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22Hiroshi Imaoka, Keita Sasaki, Ryunosuke Machida, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2017
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori EradicationSoichiro Sue, Hirofumi Kuwashima, Yuri Iwata, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 25, 2024
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1)Shuichi Mitsunaga, Masafumi Ikeda, Shogo Nomura, et al.
Pageof 6